DRMADermata Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Dermata Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DRMAEsta | $3M#3 | — | 0.9x#5 | — | — | 38.5%#3 | — | -216.7%#5 | — | — | -78.0%#3 | — |
| GRI | $3M#1 | — | 0.3x#2 | — | -100.0%#6 | -45.7%#7 | — | -116.3%#4 | — | — | -96.7%#4 | — |
| SXTP | $3M#2 | — | 1.2x#6 | 3.2x#5 | 65.5%#1 | 7.3%#4 | -771.6%#3 | -281.7%#6 | -163.8%#1 | 6#1 | — | — |
| PTPI | $3M#4 | 0.1x#3 | 3.8x#7 | 0.5x#2 | -12.2%#3 | 113.4%#1 | -90.8%#2 | 273.0%#1 | — | — | -50.7%#1 | — |
| BFRGW | $3M#5 | — | 0.4x#3 | 22.2x#6 | — | 7.1%#5 | -5652.4%#6 | -93.0%#2 | -5287.3%#2 | — | -72.6%#2 | — |
| KPTI | $2M#7 | — | — | 0.0x#1 | 0.6%#2 | -156.5%#8 | -62.1%#1 | — | — | — | -98.2%#5 | — |
| APVO | $3M#6 | 0.0x#2 | 0.4x#4 | 0.8x#3 | -74.7%#5 | -7.6%#6 | -845.0%#4 | -429.8%#7 | — | — | — | — |
| ZVSA | $2M#8 | — | — | — | — | -165.1%#9 | — | — | — | — | — | — |
| ONCO | $2M#9 | 0.0x#1 | 0.2x#1 | 2.6x#4 | -67.7%#4 | 76.1%#2 | -2190.0%#5 | -104.2%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice